Ornithine decarboxylase

From WikiMD's WELLNESSPEDIA

Ornithine Decarboxylase (ODC) is an enzyme that plays a critical role in the polyamine biosynthesis pathway. Polyamines, such as putrescine, spermidine, and spermine, are essential for cell growth and differentiation. The enzyme catalyzes the decarboxylation of ornithine, a amino acid, to produce putrescine, which then serves as a precursor for the other polyamines.

Function[edit]

Ornithine Decarboxylase is pivotal in the polyamine biosynthesis pathway. Polyamines are involved in a variety of cellular processes, including DNA stabilization, gene expression, and ion channel function. By catalyzing the first step in polyamine synthesis, ODC activity is tightly regulated and is a marker for cell proliferation and growth.

Structure[edit]

The structure of Ornithine Decarboxylase is characterized by a pyridoxal phosphate (PLP) binding site, which is essential for its catalytic activity. The enzyme typically functions as a homodimer, and its activity is regulated by antizymes, which inhibit ODC by binding to it and promoting its degradation.

Regulation[edit]

The activity of Ornithine Decarboxylase is regulated at multiple levels, including transcriptional, translational, and post-translational modifications. One of the key regulatory mechanisms is the feedback inhibition by polyamines themselves, which control ODC activity and stability. Additionally, the enzyme is rapidly degraded by the 26S proteasome in a process that does not require ubiquitination, making its half-life extremely short, typically less than an hour.

Clinical Significance[edit]

Aberrant expression of Ornithine Decarboxylase has been implicated in various diseases, including cancer. Elevated levels of ODC and, consequently, polyamines have been observed in several types of tumors, suggesting that ODC may serve as a potential target for cancer therapy. Inhibitors of ODC, such as eflornithine, have been explored for their therapeutic potential in treating cancer and other diseases characterized by excessive cell proliferation.

Inhibitors[edit]

Eflornithine is a well-known inhibitor of Ornithine Decarboxylase. It acts by irreversibly binding to the enzyme, thereby preventing the synthesis of polyamines. Eflornithine has been used in the treatment of hirsutism and is also being investigated for its efficacy in cancer therapy.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.